CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,490 | -13.0% | 21,000 | 0.0% | 0.20% | -21.1% |
| Q2 2023 | $282,240 | -18.9% | 21,000 | 0.0% | 0.26% | -33.2% |
| Q1 2023 | $348,180 | -6.4% | 21,000 | +5.0% | 0.38% | -52.8% |
| Q4 2022 | $372,000 | +44.2% | 20,000 | -0.7% | 0.81% | -11.3% |
| Q3 2022 | $258,000 | +17.3% | 20,145 | -24.0% | 0.92% | +435.1% |
| Q1 2022 | $220,000 | -35.1% | 26,500 | -47.0% | 0.17% | -36.2% |
| Q4 2021 | $339,000 | – | 50,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |